Recurrent Group C Streptococcal tonsillopharyngitis in an adolescent

Morgan, Maria C.; Rice, Lynn

doi:10.1016/0197-0070(89)90223-4

Cited by 3 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Forty of these studies had to be excluded. Twenty-nine did not have data specific for GCS [19,26,[38][39][40][41][42][43][44][45][46][47][48][49] not published in English [50,51], found to be isolated case reports not relevant to the research question [52][53][54][55][56][57]. Furthermore, 16 studies were excluded since they were not case-control studies [4][5][6]26,[58][59][60][61][62][63][64][65][66][67][68][69].…”

Section: Resultsmentioning

confidence: 99%

Group C beta hemolytic Streptococci as a potential pathogen in patients presenting with an uncomplicated acute sore throat – a systematic literature review and meta-analysis

Gunnarsson

Manchal

2020

Scandinavian Journal of Primary Health Care

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Group C beta hemolytic Streptococci as a potential pathogen in patients presenting with an uncomplicated acute sore throat – a systematic literature review and meta-analysis

Gunnarsson

Manchal

2020

Scandinavian Journal of Primary Health Care

View full text Add to dashboard Cite

show abstract

“…At least 12 original studies, mostly case series and case reports, described severe symptoms or complications following acute sore throat associated with group C and group G streptococci (Table 8; [12,25–35]). Cases of severe or recurrent pharyngitis because of group C streptococci have been reported.…”

Section: Bacterial Pathogens In Sore Throatmentioning

confidence: 99%

Guideline for the management of acute sore throat

Pelucchi

Grigoryan

Galeone

et al. 2012

Clinical Microbiology and Infection

251

230

View full text Add to dashboard Cite

Clin Microbiol Infect 2012; 18 (Suppl. 1): 1–27 Abstract The European Society for Clinical Microbiology and Infectious Diseases established the Sore Throat Guideline Group to write an updated guideline to diagnose and treat patients with acute sore throat. In diagnosis, Centor clinical scoring system or rapid antigen test can be helpful in targeting antibiotic use. The Centor scoring system can help to identify those patients who have higher likelihood of group A streptococcal infection. In patients with high likelihood of streptococcal infections (e.g. 3–4 Centor criteria) physicians can consider the use of rapid antigen test (RAT). If RAT is performed, throat culture is not necessary after a negative RAT for the diagnosis of group A streptococci. To treat sore throat, either ibuprofen or paracetamol are recommended for relief of acute sore throat symptoms. Zinc gluconate is not recommended to be used in sore throat. There is inconsistent evidence of herbal treatments and acupuncture as treatments for sore throat. Antibiotics should not be used in patients with less severe presentation of sore throat, e.g. 0–2 Centor criteria to relieve symptoms. Modest benefits of antibiotics, which have been observed in patients with 3–4 Centor criteria, have to be weighed against side effects, the effect of antibiotics on microbiota, increased antibacterial resistance, medicalisation and costs. The prevention of suppurative complications is not a specific indication for antibiotic therapy in sore throat. If antibiotics are indicated, penicillin V, twice or three times daily for 10 days is recommended. At the present, there is no evidence enough that indicates shorter treatment length.

show abstract